Novo Nordisk A/S
Contact us CONTACT US Sitemap SITEMAP index INDEX Search SEARCH THE ANNUAL REPORT index NOVONORDISK.COM

Key performance indicators

This page has been assessed by PricewaterhouseCoopersSend to a friendPrint

In 2004 Novo Nordisk began to report on the company's financial and non-financial performance in one inclusive document, the Annual Report. This move reflects the company's objective to 'strive to conduct its activities in a financially, environmentally and socially responsible way'. Recognising that truly integrated reporting is more than putting two documents into one volume, Novo Nordisk has embarked on a process to further integrate reporting practices.

This entails alignment of key priorities, target-setting and definition of key performance indicators in consultations that involve internal and external stakeholders. This is done in respect of current best practice and the principles of materiality, completeness and responsiveness. Data definitions are given under Accounting policies.

One step in this direction is a revision of past years' format for reporting on the company's sustainability-driven activities. The Environmental and social highlights table and the Triple Bottom Line performance indicators presented in Novo Nordisk Annual Report 2004 have been reviewed on the basis of feedback from stakeholders and as part of the assurance process. As a result, material performance data are presented in the Non-financial highlights.

The non-financial statements in the following pages present and discuss performance during 2005. The selection of information reflects evolving priorities in response to business and societal challenges.

To ensure transparency, an update of the complete datatable Environmental and social highlights table and the  Triple Bottom Line performance indicators is available together with interactive charts for underlying data.

Key performance indicators are organised as:

  • Economic impacts
  • Environmental impacts
  • Social impacts

See also the Management report and discussion.

 

This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.

 Novo Nordisk A/S 2006